🇺🇸 FDA
Patent

US 10556916

Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography

granted A61KA61K51/0478A61K51/1203

Quick answer

US patent 10556916 (Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K51/0478, A61K51/1203